Blog Post by Admin
Press Release
Mar 8, 2022
Cognito Therapeutics and Aetion announce partnership to use artificial intelligence to identify rapidly progressing forms of mild cognitive impairment and Alzheimer's disease
CAMBRIDGE, Mass. & NEW YORK--( BUSINESS WIRE)-- Cognito Therapeutics, a pioneer in ...
Start Reading
News
Feb 7, 2022
Using real-world evidence to advance COVID-19 medical countermeasures
The project focuses on rapidly assessing the safety and effectiveness of COVID-19 ...
Start Reading
News
Jan 4, 2022
Aetion acquires Replica Analytics to bring aboard synthetic data capabilities
Health analytics firm Aetion has acquired Replica Analytics, a company that specializes ...
Start Reading
News
Jan 4, 2022
Real-world evidence firm Aetion grabs privacy-protected synthetic data provider Replica Analytics
Aetion, which provides real-world evidence and analytics to drug companies, payers, life ...
Start Reading
News
Jan 4, 2022
Aetion snaps up AI health data specialist Replica Analytics
Aetion's acquisition of artificial intelligence data specialist Replica Analytics gives ...
Start Reading
News
Jan 4, 2022
Aetion acquires synthetic data platform Replica Analytics
This acquisition allows Aetion to solve for one of the toughest problems in RWE: access ...
Start Reading
News
Jan 4, 2022
Aetion snaps up synthetic real-world data company Replica Analytics
Less than a year after Aetion landed $110 Million in Series C funding, Aetion acquires ...
Start Reading
Press Release
Jan 4, 2022
Aetion acquires synthetic data trailblazer Replica Analytics
NEW YORK, NY and OTTAWA, ON, January 4, 2022 — Aetion, the leading regulatory-grade ...
Start Reading
Press Release
Dec 1, 2021
European Medicines Agency selects Aetion to support safety and efficacy research in Europe
BARCELONA, SPAIN, December 1, 2021 — The European Medicines Agency (EMA) has selected ...
Start Reading
News
Oct 26, 2021
FDA, Aetion expand RWE work to focus on inpatient COVID-19 therapies
FDA and Aetion announced they will use the Aetion Evidence Platform® to gather real-world ...
Start Reading
News
Oct 21, 2021
How to collect and submit RWD to win approval for a new drug indication: FDA spells it out in a long-awaited guidance
EndPoints News reports in 2021 that real-world data are messy. There can be differences ...
Start Reading
News
Oct 21, 2021
FDA contracts Aetion’s real-world evidence platform to assess COVID-19 treatments
The Food and Drug Administration has contracted with real-world evidence company Aetion ...
Start Reading
News
Oct 21, 2021
Real-world evidence: 'Labor-intensive' data standardization may be required by US FDA
New draft guidance offers recommendations for translating real-world data from claims or ...
Start Reading
Press Release
Oct 21, 2021
Aetion FDA | FDA selects Aetion Evidence Platform® to advance regulatory science and innovation
NEW YORK, NY, October 21, 2021 — Today, Aetion announces that it is expanding its ...
Start Reading
News
Oct 17, 2021
Heard at HLTH: Can we get Ironman’s J.A.R.V.I.S. in the world of drug development?
MedCity News 2021 writes that at the recent HLTH conference, a panel discussed the role ...
Start Reading
News
Oct 15, 2021
FDA adcomm votes unanimously in support of a J&J Covid-19 booster two months after one-dose shot
The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) ...
Start Reading
News
Oct 7, 2021
England’s NICE starts work to develop RWE standards
NICE collaborates with Aetion to leverage real-world evidence studies to address evidence ...
Start Reading
News
Oct 6, 2021
Aetion to collaborate with UK's NICE on RWE
New York-based real-world evidence (RWE) firm Aetion is partnering with the National ...
Start Reading
Press Release
Oct 6, 2021
Aetion and NICE announce collaboration to explore use of real-world evidence for comparative effectiveness studies to inform clinical guidance
NEW YORK, NY & MANCHESTER, ENGLAND, October 6, 2021 — Aetion today announced a ...
Start Reading
News
Oct 5, 2021
Industry Voices—COVID-19 vaccine rollout shows real-world evidence was ready for the spotlight
The incredibly fast development and rollout of the vaccines would not have been possible ...
Start Reading
Press Release
Sep 22, 2021
Aetion and Quinten Health partner to use AI and RWE to reduce research timelines
NEW YORK AND PARIS, September 22, 2021 — Quinten Health, a Paris-based AI solutions ...
Start Reading
News
Sep 21, 2021
Johnson & Johnson announces real-world evidence and Phase 3 data confirming strong and long-lasting protection of single-shot COVID-19 vaccine in the U.S.
Johnson & Johnson announced new data confirming the durability and efficacy of its ...
Start Reading
Press Release
Sep 14, 2021
Aetion welcomes Marla Kessler as first Chief Customer Officer to accelerate its next phase of growth
Aetion, a leading health technology company, announces that Marla Kessler will become its ...
Start Reading
News
Aug 3, 2021
Syneos Health and Aetion partner to offer real-world evidence solutions
Syneos Health and Aetion have announced a partnership to provide regulatory-grade data ...
Start Reading